Muar: Perdana Menteri, Tan Sri Muhyiddin Yassin mengarahkan bekalan vaksin Covid-19 negara yang dijangka tiba Mac ini, disegerakan penghantarannya.
Muhyiddin berkata, langkah itu bagi memastikan kesihatan rakyat terus terjamin di samping memastikan bekalan vaksin Covid-19 negara boleh digunakan segera.
Vaccine makers, including two of the biggest in the world, suffered setbacks in the push to get more Covid-19 shots across the line, tempering a run of positive news. Sanofi and GlaxoSmithKline Plc delayed advanced trials of their experimental Covid-19 shot after it failed to produce a strong enough response in older people, pushing its potential availability to the end of next year. In another blow, trials of a vaccine being developed by CSL Ltd. and the University of Queensland in Australia ran into difficulties. Sanofi and its U.K. partner will begin a new second-phase study with a more concentrated antigen in February after they said the current dosage failed to generate a good immune response in people 50 years and older. Younger adults showed a response similar to patients who have recovered from the disease. The problem arose after two different reagents used to measure vaccine formulations provided inaccurate information about the concentration of antigens, Sanofi said in an emailed statement. The companies notified U.S. officials about the matter. The delay underscores the difficulties and uncertainties companies face in developing shots in record time against a disease that’s already claimed more than 1.5 million lives. It’s also a blow for governments that were counting on supplies from the two vaccine giants amid expectations the world will need multiple inoculations to stop the spread of the pathogen. Australia meanwhile canceled an order for 51 million doses of a Covid shot being developed by CSL and the Australian university. A component of the vaccine comes from the human immunodeficiency virus, and while that posed no risk of infection, some trial participants had false positive tests for HIV.
The announcements temper some of the optimism following positive trial results from Pfizer Inc. and Moderna Inc. Another inoculation from AstraZeneca Plc and the University of Oxford looks promising, too, despite questions about its effectiveness in older adults. The U.K. and Canada have already approved a shot from Pfizer and partner BioNTech SE that employs messenger RNA technology, and the U.S. and Europe may do so soon. China and Russia have already begun administering their own vaccinations. Sanofi fell as much as 3.3% Friday in Paris, while Glaxo was little changed in London.
UlarSawa dont say you will use cansino vaccine. no one with common sense will believe you. correct? 13/12/2020 4:37 PM
lambo making huge profit but the share just wont move, then should be something wrong, right? u everyday mentioned what u eat during lunch and dinner, the share price also wont move, right?
UlarSawa dont assume I have lambo share. I m at lambo forum to kirim salam only. correct? 13/12/2020 4:47 PM
u keep ask question like a PRO in different counter, try to challenge others, but u didnt ask any in LAMBO, so we can assume u own the shares there, correct?
if u didnt own the share, since u always lepak there, u can also do some sharing instead of keep asking question only? right?
Bahrain approved the registration of the Sinopharm Group Co Ltd. vaccine against the coronavirus, about a week after the United Arab Emirates registered the Chinese-made vaccine.
“Results from Phase III clinical trials showed an 86% efficacy rate, a 99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of Covid-19,” the National Health Regulatory Authority said in a statement Sunday.
Bahrain has participated in phase III clinical trials, in which more than 7,700 volunteers signed up. Bahrain had previously authorized the emergency use of the vaccine, which was provided to frontline workers in contact with coronavirus patients.
The UAE registered the Sinopharm vaccine after finding it had a 86% efficacy rate, paving the way for a full public use and allowing for a re-opening of the Gulf nation’s economy.
Egypt plans to start the process of inoculation against the coronavirus after receiving the first shipments of Sinopharm vaccine.
Victorino Lee9fold, while everyone go for vaccine, Mobbs69 (master of big bull shit69) will use the glove and mask. glove still suit him. 13/12/2020 4:50 PM
yes, he irritated me alot. everyone can voice their opinions, but not to attack or curse ppl or the stock itself
this fella go all vaccine counter to curse, which deserves a selipar on his face
this fella surely buy at peak and now suffer huge losses, thats why come here to show his emo
1968 is an old man, maybe he lost all the money in glove stock recently, and maybe his wife just divorce with him..maybe he has those tragedies... And now he is just like a witch go to curse people... Cursing stocks... And I would like to teach you guys... Learn from Gratitude and love.... The Mobbs68 old man is just short of love and gratitude, so turn to be like haters to the world, everyone owe him. He is a pity man. Pity man always a reason to be pity. Cheers for tomorrow. Ignore the negativity animal.
Lee9fold I would like to give you some positive energy here, my master team asking his members to switch from glove stocks to vaccine, especially bintai and solution. The team member is more than one thousand people. So not to worry about.
Govt to increase Covid-19 vaccine purchase to cover 60%-70% of M'sians — PM
The government has plans to increase its purchase of the Covid-19 vaccine to cover the immunisation needs of about 60%-70% of Malaysians compared with 30% currently.
Prime Minister Tan Sri Muhyiddin Yassin said this was because some nations had purchased doses exceeding their population.
“As for Malaysia, we have already got 30%. I have instructed Health Minister Datuk Seri Dr Adham Baba along with [Science, Technology and Innovation Minister] Khairy Jamaluddin Abu Bakar to negotiate and increase it from 30% to 60% or 70%.
Government want to supply 60-70% vaccines. TSMY said. if all given free jab. left how many to private side to supply. very little only. good news or bad news? think before tomorrow bursa open shop. correct?
YES Any vaccine available will be G to G and not through private
UlarSawa Government want to supply 60-70% vaccines. TSMY said. if all given free jab. left how many to private side to supply. very little only. good news or bad news? think before tomorrow bursa open shop. correct? 13/12/2020 7:01 PM
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
mobbs68
740 posts
Posted by mobbs68 > 2020-12-13 15:26 | Report Abuse
Price History of con n goreng stock Solution
Promote by best snake oil salesman ie joyvest
Date Open High Low Close Volume Value Transactions
Week : 33
13/08/2020 0.260 0.265 0.240 0.250 9.053m 2.292m 381
12/08/2020 0.230 0.255 0.225 0.250 17.552m 4.244m 785
11/08/2020 0.285 0.290 0.205 0.220 16.615m 4.178m 709
10/08/2020 0.300 0.300 0.265 0.275 18.939m 5.315m 755
Week : 32
07/08/2020 0.230 0.300 0.230 0.250 39.877m 10.396m 1,738
06/08/2020 0.165 0.200 0.160 0.200 18.569m 3.319m 687
05/08/2020 0.145 0.165 0.145 0.160 20.694m 3.113m 723
04/08/2020 0.110 0.135 0.105 0.135 20.225m 2.447m 507
03/08/2020 0.100 0.110 0.095 0.105 3.978m 407,750.50 119
Week : 31
30/07/2020 0.095 0.100 0.095 0.100 2.094m 200,326.00 50
29/07/2020 0.100 0.105 0.095 0.100 484,700 48,250.00 21
28/07/2020 0.100 0.105 0.095 0.100 1.125m 112,207.50 52
27/07/2020 0.100 0.105 0.100 0.105 686,700 69,093.50 27
Week : 30
24/07/2020 0.105 0.110 0.095 0.100 2.353m 238,466.50 71
23/07/2020 0.100 0.110 0.100 0.110 3.499m 363,561.50 102
22/07/2020 0.100 0.100 0.095 0.100 1.330m 132,800.00 46
21/07/2020 0.090 0.100 0.090 0.095 3.282m 316,198.50 156
20/07/2020 0.090 0.095 0.090 0.090 587,500 52,982.50 21
Week : 29
17/07/2020 0.090 0.095 0.090 0.095 590,200 53,368.00 22
16/07/2020 0.090 0.090 0.090 0.090 1.286m 115,704.00 37
15/07/2020 0.090 0.100 0.085 0.095 3.159m 292,292.00 60
14/07/2020 0.090 0.090 0.085 0.085 2.030m 180,457.00 48
13/07/2020 0.095 0.095 0.090 0.090 1.872m 170,280.00
Date Open High Low Close Volume Value Transactions
Week : 16
13/04/2020 0.060 0.060 0.060 0.060 242,100 14,526.00 10
Week : 15
10/04/2020 0.060 0.060 0.060 0.060 200,000 12,000.00 4
09/04/2020 - 0.000 0.000 0.000 0 0.00 0
08/04/2020 0.060 0.060 0.060 0.060 247,100 14,826.00 18
07/04/2020 0.060 0.065 0.060 0.065 336,000 20,160.50 17
06/04/2020 0.050 0.060 0.050 0.055 751,000 39,535.50 19
Week : 14
03/04/2020 0.055 0.055 0.055 0.055 60,000 3,300.00 2
02/04/2020 0.055 0.055 0.055 0.055 50,000 2,750.00 2
01/04/2020 0.050 0.060 0.050 0.055 434,600 23,165.50 21
31/03/2020 0.055 0.060 0.050 0.055 740,100 38,562.50 21
30/03/2020 0.055 0.055 0.055 0.055 35,000 1,925.00 2
Week : 13
27/03/2020 0.055 0.065 0.055 0.065 823,800 48,610.00 20
26/03/2020 0.050 0.055 0.050 0.055 190,000 10,400.00 6
25/03/2020 0.055 0.060 0.055 0.055 470,100 26,530.50 20
24/03/2020 0.050 0.055 0.050 0.055 96,000 4,825.00 6
23/03/2020 0.050 0.050 0.045 0.050 462,000 21,300.00 13
Week : 12
20/03/2020 0.050 0.055 0.050 0.055 625,000 32,470.00 25
19/03/2020 0.050 0.050 0.045 0.045 917,000 45,550.00 17
18/03/2020 0.050 0.050 0.050 0.050 423,900 21,195.00 17
17/03/2020 0.045 0.060 0.045 0.055 902,500 46,110.50 34
16/03/2020 0.055 0.055 0.045 0.045 697,400 34,728.00